Found: 143
Select item for more details and to access through your institution.
Exenatide modulates visual cortex responses.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Invasive methods for detection of Helicobacter pylori infection in gastric disorders patients undergoing endoscopy from Mosul city, Iraq.
- Published in:
- Romanian Journal of Infectious Diseases / Revista Romana de de Boli Infectioase, 2024, v. 27, n. 2, p. 105, doi. 10.37897/RJID.2024.2.11
- By:
- Publication type:
- Article
Increase in endogenous glucose production with SGLT2 inhibition is attenuated in individuals who underwent kidney transplantation and bilateral native nephrectomy.
- Published in:
- Diabetologia, 2020, v. 63, n. 11, p. 2423, doi. 10.1007/s00125-020-05254-w
- By:
- Publication type:
- Article
Decreased basal hepatic glucose uptake in impaired fasting glucose.
- Published in:
- Diabetologia, 2017, v. 60, n. 7, p. 1325, doi. 10.1007/s00125-017-4252-0
- By:
- Publication type:
- Article
Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
- Published in:
- Acta Diabetologica, 2011, v. 48, n. 3, p. 209, doi. 10.1007/s00592-011-0285-x
- By:
- Publication type:
- Article
Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin.
- Published in:
- Acta Diabetologica, 2008, v. 45, n. 3, p. 147, doi. 10.1007/s00592-008-0033-z
- By:
- Publication type:
- Article
A randomised crossover trial: Exploring the dose–response effect of carbohydrate restriction on glycaemia in people with well‐controlled type 2 diabetes.
- Published in:
- Journal of Human Nutrition & Dietetics, 2023, v. 36, n. 1, p. 51, doi. 10.1111/jhn.13030
- By:
- Publication type:
- Article
Real‐world effectiveness of sodium‐glucose cotransporter‐2 inhibitors on the progression of chronic kidney disease in patients without diabetes, with and without albuminuria.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3058, doi. 10.1111/dom.15623
- By:
- Publication type:
- Article
The impact of increased hepatic glucose production caused by empagliflozin on plasma glucose concentration in individuals with type 2 diabetes and nondiabetic individuals.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 3, p. 1033, doi. 10.1111/dom.15404
- By:
- Publication type:
- Article
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 2, p. 426, doi. 10.1111/dom.14885
- By:
- Publication type:
- Article
Type 2 diabetes subgroups and response to glucose‐lowering therapy: Results from the EDICT and Qatar studies.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 9, p. 1810, doi. 10.1111/dom.14767
- By:
- Publication type:
- Article
Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 6, p. 1150, doi. 10.1111/dom.14687
- By:
- Publication type:
- Article
Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT).
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 5, p. 899, doi. 10.1111/dom.14650
- By:
- Publication type:
- Article
Insulin secretion is a strong predictor for need of insulin therapy in patients with new‐onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 7, p. 1631, doi. 10.1111/dom.14383
- By:
- Publication type:
- Article
Combination therapy with pioglitazone/exenatide improves beta‐cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3‐year follow‐up of the Qatar study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2287, doi. 10.1111/dom.14153
- By:
- Publication type:
- Article
Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin‐treated T2DM patients: Results from the Qatar Study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 705, doi. 10.1111/dom.13546
- By:
- Publication type:
- Article
Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 1075, doi. 10.1111/dom.13189
- By:
- Publication type:
- Article
Sodium-glucose co-transporter ( SGLT) and glucose transporter ( GLUT) expression in the kidney of type 2 diabetic subjects.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 9, p. 1322, doi. 10.1111/dom.13003
- By:
- Publication type:
- Article
Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 809, doi. 10.1111/dom.12881
- By:
- Publication type:
- Article
SARS-CoV-2 Testing of Aerosols Emitted During Pediatric Minimally Invasive Surgery: A Prospective, Case-Controlled Study.
- Published in:
- American Surgeon, 2022, v. 88, n. 11, p. 2710, doi. 10.1177/00031348211067707
- By:
- Publication type:
- Article
Oncologic Fidelity of Minimally Invasive Surgery to Resect Neoadjuvant-Treated Wilms Tumors.
- Published in:
- American Surgeon, 2022, v. 88, n. 5, p. 943, doi. 10.1177/00031348211070796
- By:
- Publication type:
- Article
Increased lipid availability for three days reduces whole body glucose uptake, impairs muscle mitochondrial function and initiates opposing effects on PGC-1α promoter methylation in healthy subjects.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188208
- By:
- Publication type:
- Article
Hepatic DsbA‐L protects mice from diet‐induced hepatosteatosis and insulin resistance.
- Published in:
- FASEB Journal, 2017, v. 31, n. 6, p. 2314, doi. 10.1096/fj.201600985R
- By:
- Publication type:
- Article
PREVALENCE OF MULTI DRUG RESISTANT AMONG SALMONELLA SPECIES ISOLATED FROM ENVIRONMENTAL SAMPLES OF MOSUL CITY.
- Published in:
- Biochemical & Cellular Archives, 2021, v. 21, p. 2097
- By:
- Publication type:
- Article
Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1392675
- By:
- Publication type:
- Article
Adiponectin Alleviates Diet-Induced Inflammation in the Liver by Suppressing MCP-1 Expression and Macrophage Infiltration.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Adaptation of Insulin Clearance to Metabolic Demand Is a Key Determinant of Glucose Tolerance.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Mild Physiologic Hyperglycemia on Insulin Secretion, Insulin Clearance, and Insulin Sensitivity in Healthy Glucose-Tolerant Subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
1851-P: Renal Denervation Attenuates Endogenous Glucose Production Increase with SGLT2 Inhibition in Patients with Renal Transplant Recipients and Impaired Fasting Glucose.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1851-P
- By:
- Publication type:
- Article
184-OR: Liver Fibrosis Scores Do Not Predict Response to Therapy in T2DM.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-184-OR
- By:
- Publication type:
- Article
352-OR: Combination Therapy with Dapagliflozin plus Exenatide on Endogenous Glucose Production: A Mechanism of Action Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-352-OR
- By:
- Publication type:
- Article
1136-P: Glucose Kinetics during Oral Glucose Challenge following Administration of Exenatide and Dapagliflozin Alone and in Combination in Type 2 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1136-P
- By:
- Publication type:
- Article
Evidence Against an Important Role of Plasma Insulin and Glucagon Concentrations in the Increase in EGP Caused by SGLT2 Inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
155-LB: The Increase in Endogenous Glucose Production with SGLT2 Inhibition Is Unchanged by Renal Denervation but Highly Correlates to Urinary Glucose Excretion.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-155-LB
- By:
- Publication type:
- Article
246-OR: Contribution of Plasma Glucose and Hormones to the Acute Compensatory Rise in Endogenous Glucose Production (EGP) during Glucosuria in T2D Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-246-OR
- By:
- Publication type:
- Article
245-OR: Glucose Production and Utilization following Oral Glucose Load in Type 2 Diabetes Patients Treated with Dapagliflozin Alone and in Saxagliptin Combination.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-245-OR
- By:
- Publication type:
- Article
1935-P: Decoupling between ATP Utilization and Replenishment in Insulin Resistant Skeletal Muscle.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1935-P
- By:
- Publication type:
- Article
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects With Normal Glucose Tolerance.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Endogenous Glucose Production and Hormonal Changes in Response to Canagliflozin and Liraglutide Combination Therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Empagliflozin and Kinetics of Renal Glucose Transport in Healthy Individuals and Individuals With Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chronic Reduction of Plasma Free Fatty Acid Improves Mitochondrial Function and Whole-Body Insulin Sensitivity in Obese and Type 2 Diabetic Individuals.
- Published in:
- Diabetes, 2014, v. 63, n. 8, p. 2811, doi. 10.2337/db13-1130
- By:
- Publication type:
- Article
Novel Hypothesis to Explain Why SGLT2 Inhibitors Inhibit Only 30-50% of Filtered Glucose Load in Humans.
- Published in:
- Diabetes, 2013, v. 62, n. 10, p. 3324, doi. 10.2337/db13-0604
- By:
- Publication type:
- Article
Distinct β-cell defects in impaired fasting glucose and impaired glucose tolerance.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Distinct β-Cell Defects in Impaired Fasting Glucose and Impaired Glucose Tolerance.
- Published in:
- Diabetes, 2012, v. 61, n. 2, p. 447, doi. 10.2337/db11-0995
- By:
- Publication type:
- Article
Reduction in Reactive Oxygen Species Production by Mitochondria From Elderly Subjects With Normal and Impaired Glucose Tolerance.
- Published in:
- Diabetes, 2011, v. 60, n. 8, p. 2051, doi. 10.2337/db11-0121
- By:
- Publication type:
- Article
Deleterious Effect of Elevated Fatty Acid Metabolites Concentration on Skeletal Muscle Mitochondrial Atp Synthesis.
- Published in:
- Diabetes, 2007, v. 56, p. A337
- By:
- Publication type:
- Article
Contribution of Non Insulin Dependent Glucose Clearance to the Rise in FPG in the Non-Diabetic Range.
- Published in:
- Diabetes, 2007, v. 56, p. A328
- By:
- Publication type:
- Article
Short-Term Elevation of Plasma Free Fatty Acids (FFA) Decreases Skeletal Muscle Mitochondrial Membrane Potential in Healthy Glucose Tolerant Subjects.
- Published in:
- Diabetes, 2007, v. 56, p. A63
- By:
- Publication type:
- Article
Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study.
- Published in:
- 2006
- By:
- Publication type:
- journal article